MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2022 International Congress

    FDG-PET features of Lewy body dementia among patients with amnestic presentations typical for Alzheimer’s disease

    J. Silva-Rodríguez, MA. Labrador-Espinosa, A. Moscoso, M. Schöll, P. Mir, M. Grothe (Sevilla, Spain)

    Objective: To better understand the role of FDG-PET for identifying dementia with Lewy bodies (DLB) in the context of Alzheimer’s disease (AD)-like amnestic presentations, we…
  • 2022 International Congress

    Multimodal assessment of nigrostriatal degeneration in de novo Parkinson’s disease

    M. López-Aguirre, M. Matarazzo, J. Blesa, A. Sánchez-Ferro, M. Hm Monje, J. Obeso, J. Pineda-Pardo (Móstoles, Spain)

    Objective: To study nigrostriatal changes with a multifactorial neuroimaging approach in order to further characterize early abnormalities in Parkinson’s Disease (PD). Background: Imaging techniques allow…
  • 2022 International Congress

    Effect of exercise on brain metabolism and energetics in PD

    C. Bevington, R. Jayde Williams, B. Pike, J. Mckenzie, J. Zhang, W. Luh, AJ. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identity the effect of exercise on brain metabolism and energetics in PD using PET/MR imaging. Background: Aerobic exercise slows PD progression as reflected…
  • 2022 International Congress

    Feasibility of artificial intelligence in predicting early phenotype conversion of REM Sleep Behavior Disorder

    L. Lopes, P. Wu, J. Lu, J. Wang, C. Bassetti, A. Rominger, C. Zuo, H. Yu, K. Shi (Bern, Switzerland)

    Objective: The goal of this study was to investigate the feasibility of deep learning in the prediction of disease conversion in RBD patients. Background: Rapid…
  • 2022 International Congress

    Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up

    T. Fedorova, K. Knudsen, K. Andersen, J. Horsager, C. Skjærbæk, M. Otto, K. Svendsen, P. Borghammer (Aarhus N, Denmark)

    Objective: To image progression of intestinal dysfunction, cardiac sympathetic denervation, and dopaminergic nigrostriatal damage in patients with isolated REM sleep behaviour disorder (iRBD). Background: A…
  • 2022 International Congress

    Visualising cholinergic nerves in dementia with Lewy bodies using PET and FEOBV

    N. Okkels, J. Horsager, A. Hansen, M. Damholdt, P. Kjeldsen, K. Vestergaard, K. Andersen, C. Skjærbæk, T. Fedorova, J. Mortensen, G. Bekan, H. Gottrup, P. Borghammer (Aarhus N, Denmark)

    Objective: Investigate the cholinergic integrity of the central nervous system in dementia with Lewy bodies using PET and a tracer for the vesicular acetylcholine transporter.…
  • 2022 International Congress

    [18F]FDG PET in hyperkinetic movement disorders: a systematic review

    E. Timmers, M. Klamer, R. Marapin, A. Lammertsma, B. de Jong, R. Dierckx, M. Tijssen (Groningen, Netherlands)

    Objective: To give a comprehensive literature overview of alterations in regional cerebral glucose metabolism, measured using [18F]FDG PET, in hyperkinetic movement disorders. In addition, correlations…
  • 2022 International Congress

    Does autosomal recessive Parkinson’s Disease behave as “Brain-first” subtype?

    B. Soydas-Turan, G. Yalcin-Cakmakli, B. Volkan-Salanci, E. Lay-Ergun, B. Elibol (Ankara, Turkey)

    Objective: The aim of this study is to explore whether monogenic PD (due to parkin or DJ-1 homozygous mutations) can be subtyped as "brain-first" by…
  • 2022 International Congress

    Muscarinic M2 cholinergic receptors in cervical dystonia

    P. Kassavetis, M. Hosseini, K. Mente, R. Waugh, E. Shamim, W. Dieckmann, P. Herscovitch, M. Hallett, S. Horovitz (Salt Lake City, USA)

    Objective: To characterize the M2 muscarinic acetylcholine receptor binding in patients with cervical dystonia, measured with non-invasive high-resolution PET, using [18F]FP-TZTP ligand. Background: While antimuscarinic…
  • 2022 International Congress

    Retinal thickness as a marker of disease progression in progressive supranuclear palsy

    Y. Chen, H. Wang, B. Wang, B. Li, P. Ye, W. Xu, P. Liu, X. Chen, Z. Cen, Z. Ouyang, S. Wu, X. Dou, Y. Liao, W. Luo (Hangzhou, China)

    Objective: We measured changes of retinal thickness, and compare them with clinical features and intracranial neurodegeneration in progressive supranuclear palsy (PSP) cohort. Background: PSP has a…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 40
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley